These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22754048)

  • 41. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.
    Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B
    Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition.
    Higgins GA; Ballard TM; Huwyler J; Kemp JA; Gill R
    Neuropharmacology; 2003 Mar; 44(3):324-41. PubMed ID: 12604092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketamine.
    Banerjee P; Donello JE; Hare B; Duman RS
    Behav Brain Res; 2020 Aug; 391():112706. PubMed ID: 32461133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
    Lemercier CE; Holman C; Gerevich Z
    Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.
    Ahnaou A; de Boer P; Lavreysen H; Huysmans H; Sinha V; Raeymaekers L; Van De Casteele T; Cid JM; Van Nueten L; Macdonald GJ; Kemp JA; Drinkenburg WH
    Neuropharmacology; 2016 Apr; 103():290-305. PubMed ID: 26686390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
    Jones NC; Reddy M; Anderson P; Salzberg MR; O'Brien TJ; Pinault D
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):657-68. PubMed ID: 21733235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain.
    Sharma AC; Kulkarni SK; Nayar U
    Indian J Exp Biol; 1991 Aug; 29(8):744-50. PubMed ID: 1837539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep deficits in rats after NMDA receptor blockade.
    Stone WS; Walker DL; Gold PE
    Physiol Behav; 1992 Sep; 52(3):609-12. PubMed ID: 1409928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic blockade of N-methyl-D-aspartate receptors alters gamma-aminobutyric acid type A receptor peptide expression and function in the rat.
    Matthews DB; Kralic JE; Devaud LL; Fritschy JM; Morrow AL
    J Neurochem; 2000 Apr; 74(4):1522-8. PubMed ID: 10737609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat.
    Maloney KJ; Cape EG; Gotman J; Jones BE
    Neuroscience; 1997 Jan; 76(2):541-55. PubMed ID: 9015337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.
    Castro-Zaballa S; Cavelli ML; Gonzalez J; Nardi AE; Machado S; Scorza C; Torterolo P
    Front Psychiatry; 2018; 9():766. PubMed ID: 30705645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze.
    Guscott MR; Clarke HF; Murray F; Grimwood S; Bristow LJ; Hutson PH
    Eur J Pharmacol; 2003 Aug; 476(3):193-9. PubMed ID: 12969766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
    Sharma AC; Thorat SN; Nayar U; Kulkarni SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):111-6. PubMed ID: 1838740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.
    Lindén A; Storvik M; Lakso M; Haapasalo A; Lee D; Witkin JM; Sei Y; Castrén E; Wong G
    Neuropharmacology; 2001 Mar; 40(4):469-81. PubMed ID: 11249956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Excitation of the pedunculopontine tegmental NMDA receptors induces wakefulness and cortical activation in the rat.
    Datta S; Patterson EH; Spoley EE
    J Neurosci Res; 2001 Oct; 66(1):109-16. PubMed ID: 11599007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NMDA receptor antagonists reveal age-dependent differences in the properties of visual cortical plasticity.
    de Marchena J; Roberts AC; Middlebrooks PG; Valakh V; Yashiro K; Wilfley LR; Philpot BD
    J Neurophysiol; 2008 Oct; 100(4):1936-48. PubMed ID: 18667547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
    Walker DL; Davis M
    Learn Mem; 2008 Feb; 15(2):67-74. PubMed ID: 18230675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of aberrant gamma frequency oscillations on prepulse inhibition.
    Jones NC; Anderson P; Rind G; Sullivan C; van den Buuse M; O'Brien TJ
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1671-81. PubMed ID: 24832766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep.
    Lydic R; Baghdoyan HA
    Sleep; 2002 Sep; 25(6):617-22. PubMed ID: 12224840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.